NCT Number: NCT02462057
Testing Different Messaging Approaches to Increase Activation of a HealthyFood Benefit in Adults With Diabetes
The Vitality HealthyFood benefit is a three-tiered incentive program designed to encourage healthier food choices amongst members of Discovery Health's Vitality program. Once enrolled in the benefit, participating members can receive 10%, 15%, or 25% cash-back on the healthy foods they purchase at selected grocers. And, while overall enrollment in the program is high, there is particular interest in increasing enrollment in the benefit amongst Vitality members with diabetes. One presumed barrier to enrollment in the benefit amongst members with diabetes is a misperception of the particular relevance of the benefit and healthier food choices for their personal health. Improved messaging regarding the HealthyFood benefit and its particular salience for individuals with diabetes may be an effective means of increasing activation of the benefit in this population. The proposed study will be a collaboration between Discovery Health/Vitality and researchers at the Perelman School of Medicine at the University of Pennsylvania. In the proposed RCT, Vitality members with diabetes will be randomised to different types of messages regarding the HealthyFood benefit. The investigators will then compare the effectiveness of these different messaging strategies at increasing activation of the HealthyFood benefit amongst Vitality members with diabetes.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Adults over age 18
- Vitality health members who have not yet enrolled in the Vitality HealthyFood benefit
- Diagnosis of type 2 diabetes (based on registration for chronic benefits for type 2 diabetes)
- Have registered on to Discovery Health/Vitality website in the past (marker of Internet access and availability of email address)
Exclusion criteria
- Anyone who does not meet above criteria
Treatment and study plan
Primary outcomes
-
Enrollment in 10% Level of Benefit
Time frame: One month from initial emailed messages
Rates of enrolment in 10% cash-back level (the most basic level, requires online activation only) of the HealthyFood Benefit amongst members with diabetes
Sponsors and collaborators
Lead sponsor
University of Pennsylvania
Other
Collaborators
- Discovery Health
Registry information
Official study title
Testing the Effectiveness of Different Messaging Approaches to Increase Activation of a HealthyFood Benefit Amongst Individuals With Diabetes: A Randomised, Controlled Trial
Important dates
- Study start
- 2015
- Primary completion
- 2015
- Study completion
- 2015
- First posted
- Jun 3, 2015
- Registry last updated
- Nov 9, 2018
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Stroke Incidence and Risk Factors in a Tri-ethnic Region
NCT03266952
Brain Diseases, Cardiovascular Diseases
Miami, Florida, United States
View Trial DetailsGenetics of Type 2 Diabetes in West Africans
NCT00837122
Cardiovascular Diseases, Diabetes
Accra, Ghana
View Trial DetailsUric Acid Lowering Trial in Youth Onset T2D
NCT03899883
Diabetes, Diabetes Complications
Aurora, Colorado, United States
View Trial DetailsInvestigating the Use of Quercetin on Glucose Absorption in Obesity, and Obesity With Type 2 Diabetes
NCT00065676
Body Weight, Diabetes
Bethesda, Maryland, United States
View Trial Details